David Turner to Glycation End Products, Advanced
This is a "connection" page, showing publications David Turner has written about Glycation End Products, Advanced.
Connection Strength
3.695
-
Examination of the Effectiveness of the Healthy Empowered Active Lifestyles (HEAL) Program on Advanced Glycation End Products. Int J Environ Res Public Health. 2021 05 02; 18(9).
Score: 0.702
-
Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study. Cancer. 2020 06 01; 126(11):2648-2657.
Score: 0.647
-
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention. Breast Cancer Res Treat. 2019 Feb; 173(3):559-571.
Score: 0.590
-
The Role of Advanced Glycation End-Products in Cancer Disparity. Adv Cancer Res. 2017; 133:1-22.
Score: 0.512
-
Advanced glycation end-products: a biological consequence of lifestyle contributing to cancer disparity. Cancer Res. 2015 May 15; 75(10):1925-9.
Score: 0.463
-
AGE metabolites: a biomarker linked to cancer disparity? Cancer Epidemiol Biomarkers Prev. 2014 Oct; 23(10):2186-91.
Score: 0.439
-
Dietary Advanced Glycation End-Products and Mortality after Breast Cancer in the Women's Health Initiative. Cancer Epidemiol Biomarkers Prev. 2021 12; 30(12):2217-2226.
Score: 0.181
-
Dietary Advanced Glycation End-products (AGE) and Risk of Breast Cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO). Cancer Prev Res (Phila). 2020 07; 13(7):601-610.
Score: 0.162